BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24114143)

  • 1. CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?
    Schaft N; Wellner V; Wohn C; Schuler G; Dörrie J
    Cancer Immunol Immunother; 2013 Dec; 62(12):1769-80. PubMed ID: 24114143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.
    Schaft N; Dörrie J; Thumann P; Beck VE; Müller I; Schultz ES; Kämpgen E; Dieckmann D; Schuler G
    J Immunol; 2005 Mar; 174(5):3087-97. PubMed ID: 15728524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
    Erdmann M; Dörrie J; Schaft N; Strasser E; Hendelmeier M; Kämpgen E; Schuler G; Schuler-Thurner B
    J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.
    Van Tendeloo VF; Ponsaerts P; Lardon F; Nijs G; Lenjou M; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN
    Blood; 2001 Jul; 98(1):49-56. PubMed ID: 11418462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
    J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
    Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
    Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells.
    Hoyer S; Gerer KF; Pfeiffer IA; Prommersberger S; Höfflin S; Jaitly T; Beltrame L; Cavalieri D; Schuler G; Vera J; Schaft N; Dörrie J
    J Immunol Res; 2015; 2015():952184. PubMed ID: 26824052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies.
    Knippertz I; Stein MF; Dörrie J; Schaft N; Müller I; Deinzer A; Steinkasserer A; Nettelbeck DM
    Int J Hyperthermia; 2011; 27(6):591-603. PubMed ID: 21846195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood monocytes sample MelanA/MART1 antigen for long-lasting cross-presentation to CD8
    Faure F; Jouve M; Lebhar-Peguillet I; Sadaka C; Sepulveda F; Lantz O; Berre S; Gaudin R; Sánchez-Ramón S; Amigorena S
    Int J Cancer; 2018 Jan; 142(1):133-144. PubMed ID: 28884480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
    Kalady MF; Onaitis MW; Padilla KM; Emani S; Tyler DS; Pruitt SK
    J Surg Res; 2002 Jun; 105(1):17-24. PubMed ID: 12069496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function.
    López-Albaitero A; Mailliard R; Hackman T; Andrade Filho PA; Wang X; Gooding W; Ferrone S; Kalinski P; Ferris RL
    J Immunother; 2009 Jun; 32(5):465-73. PubMed ID: 19609238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.
    Chauvin JM; Larrieu P; Sarrabayrouse G; Prévost-Blondel A; Lengagne R; Desfrançois J; Labarrière N; Jotereau F
    J Immunol; 2012 Mar; 188(5):2102-10. PubMed ID: 22291187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.
    Barrio MM; Abes R; Colombo M; Pizzurro G; Boix C; Roberti MP; Gélizé E; Rodriguez-Zubieta M; Mordoh J; Teillaud JL
    PLoS One; 2012; 7(7):e40311. PubMed ID: 22768350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism.
    Xu S; Koski GK; Faries M; Bedrosian I; Mick R; Maeurer M; Cheever MA; Cohen PA; Czerniecki BJ
    J Immunol; 2003 Sep; 171(5):2251-61. PubMed ID: 12928369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 promotes homeostatic proliferation of human CD8(+) memory T cells and, when produced by CD1c(+) DCs, shapes naive CD8(+) T-cell priming.
    Nizzoli G; Larghi P; Paroni M; Crosti MC; Moro M; Neddermann P; Caprioli F; Pagani M; De Francesco R; Abrignani S; Geginat J
    Eur J Immunol; 2016 Jul; 46(7):1622-32. PubMed ID: 27129615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells.
    Ponsaerts P; Van den Bosch G; Cools N; Van Driessche A; Nijs G; Lenjou M; Lardon F; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunol; 2002 Aug; 169(4):1669-75. PubMed ID: 12165485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy.
    Chung DJ; Romano E; Pronschinske KB; Shyer JA; Mennecozzi M; St Angelo ET; Young JW
    J Transl Med; 2013 Jul; 11():166. PubMed ID: 23837662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient genetic modification of murine dendritic cells by electroporation with mRNA.
    Van Meirvenne S; Straetman L; Heirman C; Dullaers M; De Greef C; Van Tendeloo V; Thielemans K
    Cancer Gene Ther; 2002 Sep; 9(9):787-97. PubMed ID: 12189529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch controls generation and function of human effector CD8+ T cells.
    Kuijk LM; Verstege MI; Rekers NV; Bruijns SC; Hooijberg E; Roep BO; de Gruijl TD; van Kooyk Y; Unger WW
    Blood; 2013 Apr; 121(14):2638-46. PubMed ID: 23380742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells.
    Van Tendeloo VF; Snoeck HW; Lardon F; Vanham GL; Nijs G; Lenjou M; Hendriks L; Van Broeckhoven C; Moulijn A; Rodrigus I; Verdonk P; Van Bockstaele DR; Berneman ZN
    Gene Ther; 1998 May; 5(5):700-7. PubMed ID: 9797876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.